ClinicalTrials.Veeva

Menu

Usability, Safety and Efficacy of AspivixTM

A

Aspivix

Status

Completed

Conditions

IUD Insertion

Treatments

Device: AspivixTM cervical vacuum tenaculum

Study type

Interventional

Funder types

Industry

Identifiers

NCT04441333
Aspivix_IUD2019_Pilot

Details and patient eligibility

About

Limited mobility of the uterine cervix and alignment with the vaginal canal is often required during insertion of an intrauterine contraceptive device (IUD). Currently, the available instruments are traumatic tenacula, which could cause pain and bleeding and therefore represent an obstacle for certain patients to pursue their medical follow-up.

AspivixTM is a new device, which enables atraumatic traction of the cervix while respecting its specific semi-circular anatomic shape through a system powered by a vacuum chamber.

The aim of our pilot study is to assess the usability, safety and efficacy of the device.

Note: Study is made of 2 phases (pilot phase followed by a comparative phase). Details regarding comparative study is registered separately.

Enrollment

13 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants older than 18 years
  • Participants presenting at the outpatient clinic for Mirena IUD insertion.
  • Participants able to provide informed consent as documented by signature with at least 24 hours of reflection time
  • Good understanding of written and oral speaking used at the centre where the study will be carried out.

Exclusion criteria

  • Participants who are contraindicated for the insertion of the IUD Mirena
  • Participants under use of excessive alcohol, narcotics or benzodiazepines prior to procedure
  • Participants who do not wish to be informed of a chance discovery
  • Participant receiving anaesthetics prior to IUD insertion procedure
  • Participants on anticoagulant medication
  • Participants under use of an analgesic
  • Previous cervical operation
  • Severe vaginal bleeding
  • Participant previously enrolled in this study
  • Cervix diameter smaller than 26 mm
  • Mullerian anomalies with two cervices
  • Nabothian cyst
  • Cervical myomas
  • Cervical condylomas
  • Squamous intraepithelial lesion (Cervical dysplasia)
  • Cervical endometriosis
  • Cervical tears
  • A well exposed cervix and / or well aligned vaginal and cervical canals where no traction is required for IUD insertion
  • Other cervical abnormalities (cervical polyp, cervical lesion, or irregularity) which may contraindicate or complicate IUD insertion
  • Large ectopy, for which it is not possible to find a suitable location near the ectopy where native tissue is present
  • Large scar tissue, for which it is not possible to find a suitable location near the scar where native tissue is present

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

AspivixTM cervical vacuum tenaculum
Experimental group
Description:
Traction of the cervix for IUD insertion using the AspivixTM cervical vacuum tenaculum.
Treatment:
Device: AspivixTM cervical vacuum tenaculum

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems